Clene Stock (NASDAQ: CLNN) stock price, news, charts, stock research, profile.
Open | $0.417 |
Close | - |
Volume / Avg. | 540.220K / 935.937K |
Day Range | 0.380 - 0.420 |
52 Wk Range | 0.250 - 1.090 |
Market Cap | $53.711M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 0.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clene (NASDAQ: CLNN) through any online brokerage.
Other companies in Clene’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Clene (NASDAQ: CLNN) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 7.00 expecting CLNN to rise to within 12 months (a possible 1608.98% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Clene (NASDAQ: CLNN) is $0.4096 last updated Today at May 1, 2024 at 9:27 AM EDT.
There are no upcoming dividends for Clene.
Clene’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Clene.
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.